Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00874354 · ClinicalTrials.gov registry record · Phase 1
Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction
A Phase 1 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00874354 is a Phase 1 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 27 participants.
The verdict
NCT00874354, a Phase 1 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
This research is being done because currently there is no effective way in regenerating or replacing the heart muscle that has been damaged after a heart attack. The purpose of this study is to test whether injecting cells obtained from the patient's bone marrow into the coronary artery can regenerate and replace heart tissue to strengthen heart and prevent heart from dilating and developing heart failure.
Interventions
- DRUG Intracoronary Transplantation of Bone Marrow Stem Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00874354
The ClinicalTrials.gov registry entry for NCT00874354 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intracoronary Transplantation of Bone Marrow Stem Cells is the first listed.
NCT00874354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00874354 about?
NCT00874354 is a clinical study titled "Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction". This research is being done because currently there is no effective way in regenerating or replacing the heart muscle that has been damaged after a heart attack. The purpose of this study is to test whether injecting cells obtained from the patient's bone marrow into the coronary artery can regener...
What is the current status of trial NCT00874354?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2005-07. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00874354?
The interventions under investigation include: Intracoronary Transplantation of Bone Marrow Stem Cells (DRUG).
Who is sponsoring clinical trial NCT00874354?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.